×

Treatment of fibroproliferative disorders using TGF-beta inhibitors

  • US 20040038856A1
  • Filed: 05/16/2003
  • Published: 02/26/2004
  • Est. Priority Date: 05/17/2002
  • Status: Abandoned Application
First Claim
Patent Images

1. A method for the treatment of a fibroproliferative disease, comprising (a) identifying a non-peptide small molecule, selectively binding to a TGFβ

  • -R1 kinase receptor; and

    (b) administering an effective amount of said molecule to a mammalian subject diagnosed with said fibroproliferative disease.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×